Endogenous melatonin levels and the fate of exogenous melatonin: age effects - PubMed (original) (raw)
Endogenous melatonin levels and the fate of exogenous melatonin: age effects
I V Zhdanova et al. J Gerontol A Biol Sci Med Sci. 1998 Jul.
Abstract
This study examines the range of serum melatonin concentrations that occur among young and older adults, and tests the effects of orally administered melatonin on the serum and saliva concentrations of the hormone. Healthy volunteers (20-36 per study), aged 20-73 years, were divided into two groups on the basis of age (29.2 +/- 6.5 and 60 +/- 8.8 years). For study 1: Serum melatonin levels were measured at 15 to 60 min intervals over a 25 h period using a radioimmunoassay. For study 2: serum and saliva melatonin levels were measured before and at intervals after the administration of a 0.3 mg dose of melatonin at 11.00 h. The younger subjects had significantly higher peak endogenous melatonin concentrations (+/- SD) and greater inter-individual variability (100.9 +/- 48.6 pg/ml) than the older subjects (34.5 +/- 15.4 pg/ml). Mean melatonin levels following treatment with the hormone tended to be higher and were significantly more variable among the group of older volunteers (254.5 +/- 145.7) than among the younger group (170.2 +/- 22.0 pg/ml). We conclude that although the peak endogenous serum melatonin levels are lower in elderly adults, the increment in serum melatonin levels induced by a low oral dose of the hormone is greater and more variable among people over 48 years old.
Similar articles
- Correlation between salivary and serum melatonin: dependence on serum melatonin levels.
Laakso ML, Porkka-Heiskanen T, Alila A, Stenberg D, Johansson G. Laakso ML, et al. J Pineal Res. 1990;9(1):39-50. doi: 10.1111/j.1600-079x.1990.tb00692.x. J Pineal Res. 1990. PMID: 2231272 - Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature.
Vural EM, van Munster BC, de Rooij SE. Vural EM, et al. Drugs Aging. 2014 Jun;31(6):441-51. doi: 10.1007/s40266-014-0178-0. Drugs Aging. 2014. PMID: 24802882 Review. - Oral administration and distribution of melatonin in human serum, saliva and urine.
Vakkuri O, Leppäluoto J, Kauppila A. Vakkuri O, et al. Life Sci. 1985 Aug 5;37(5):489-95. doi: 10.1016/0024-3205(85)90412-6. Life Sci. 1985. PMID: 4021725 - Feasibility and functionality of OROS melatonin in healthy subjects.
Shah J, Langmuir V, Gupta SK. Shah J, et al. J Clin Pharmacol. 1999 Jun;39(6):606-12. doi: 10.1177/00912709922008218. J Clin Pharmacol. 1999. PMID: 10354964 Clinical Trial. - Bioavailability of oral melatonin in humans.
Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJ. Waldhauser F, et al. Neuroendocrinology. 1984 Oct;39(4):307-13. doi: 10.1159/000123997. Neuroendocrinology. 1984. PMID: 6493445
Cited by
- Melatonin Target Proteins: Too Many or Not Enough?
Liu L, Labani N, Cecon E, Jockers R. Liu L, et al. Front Endocrinol (Lausanne). 2019 Nov 15;10:791. doi: 10.3389/fendo.2019.00791. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31803142 Free PMC article. Review. - Cerebrovascular Disease in the Young Adult: Examining Melatonin's Possible Multiple Roles.
Onaolapo AY, Onaolapo OJ, Nathaniel TI. Onaolapo AY, et al. J Exp Neurosci. 2019 Feb 5;13:1179069519827300. doi: 10.1177/1179069519827300. eCollection 2019. J Exp Neurosci. 2019. PMID: 30783379 Free PMC article. Review. - Circadian Rhythm and CKD: Is Melatonin a Key Player or Bi-player?
Nagasawa Y, Hasuike Y, Kuragano T, Ishihara M. Nagasawa Y, et al. Intern Med. 2019 Jun 1;58(11):1531-1532. doi: 10.2169/internalmedicine.2323-18. Epub 2019 Feb 1. Intern Med. 2019. PMID: 30713330 Free PMC article. No abstract available. - The Safety of Melatonin in Humans.
Andersen LP, Gögenur I, Rosenberg J, Reiter RJ. Andersen LP, et al. Clin Drug Investig. 2016 Mar;36(3):169-75. doi: 10.1007/s40261-015-0368-5. Clin Drug Investig. 2016. PMID: 26692007 Review. - Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases.
Reiter RJ, Sharma R, Rosales-Corral S. Reiter RJ, et al. Int J Mol Sci. 2021 Jan 14;22(2):764. doi: 10.3390/ijms22020764. Int J Mol Sci. 2021. PMID: 33466614 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources